亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Cyclosporine targets PTEN-deficient cancer cells in a highly specific manner
總結
Rodney Rothstein, Ph.D.
技術優勢
Offers a cancer therapeutic that is cancer-specific and minimizes damage to normal cellsOffers a therapeutics agent that specifically targets PTEN-deficient cellsUtilizes a therapeutic agent that is already used in the clinical setting Patent information:Patent (WO/2012/145426)Tech Ventures Reference: IR 2902
技術應用
Cancer treatment in PTEN-deficient cancersCancer treatment to be used in combination with other cancer therapeuticsResearch tool for studying PTEN-deficient cancers Research tool for studying CypACyclosporine is an immunosuppressive drug, currently used in transplant patients.
詳細技術說明
Rodney Rothstein, Ph.D.
國家/地區
美國
欲了解更多信息，請點擊 這裡
